A humanized mouse model for a common β0-thalassemia mutation

被引:43
作者
Jamsai, D
Zaibak, F
Khongnium, W
Vadolas, J
Voullaire, L
Fowler, KJ
Gazeas, S
Fucharoen, S
Williamson, R
Ioannou, PA
机构
[1] Univ Melbourne, Royal Melbourne Hosp, CAGT Res Grp, Murdoch Childrens Res Inst,Dept Paediat, Melbourne, Vic 3052, Australia
[2] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhon Pathom 73170, Thailand
[3] Mahidol Univ, Inst Mol Biol & Genet, Nakhon Pathom 73170, Thailand
[4] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Disease Model Unit,Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia
[5] Cyprus Inst Neurol & Genet, Nicosia, Cyprus
基金
英国医学研究理事会;
关键词
bacterial artificial chromosomes; hemoglobin; beta-Thalassemia; 4-bp deletion mutation; Transgenic mice; Knockout mice; Gene correction; HbF induction;
D O I
10.1016/j.ygeno.2004.11.016
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Accurate animal models that recapitulate the phenotype and genotype of patients with beta-thalassemia would enable the development of a range of possible therapeutic approaches. Here we report the generation of a mouse model carrying the codons 41-42 (-TTCT) beta-thalassemia mutation in the intact human beta-globin locus. This mutation accounts for approximately 40% of beta-thalassemia mutations in southern China and Thailand. We demonstrate a low level of production of gamma-globins from the mutant locus in day 18 embryos, as well as production of mutant human beta-globin rnRNA. However, in contrast to transgenic mice carrying the normal human beta-globin locus, 4-bp deletion mice fail to show any phenotypic complementation of the knockout mutation of both murine beta-globin genes. Our studies suggest that this is a valuable model for gene correction in hemopoietic stem cells and for studying the effects of HbF inducers in vivo in a "humanized" thalassemic environment. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:453 / 461
页数:9
相关论文
共 37 条
[1]   GLOBIN CHAIN ELECTROPHORESIS - A NEW APPROACH TO THE DETERMINATION OF THE G-GAMMA/A-GAMMA RATIO IN FETAL HEMOGLOBIN AND TO STUDIES OF GLOBIN-SYNTHESIS [J].
ALTER, BP ;
GOFF, SC ;
EFREMOV, GD ;
GRAVELY, ME ;
HUISMAN, THJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 44 (04) :527-534
[2]  
Bunn HF., 1986, HEMOGLOBIN MOL GENET
[3]  
CHAN V, 1987, AM J HUM GENET, V41, P678
[4]   MOUSE MODEL OF HUMAN BETA(0) THALASSEMIA - TARGETED DELETION OF THE MOUSE BETA(MAJ)-GLOBIN AND BETA(MIN)-GLOBIN GENES IN EMBRYONIC STEM CELLS [J].
CIAVATTA, DJ ;
RYAN, TM ;
FARMER, SC ;
TOWNES, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9259-9263
[5]   ALLOIMMUNIZATION IN 2 MULTI-TRANSFUSED PATIENT POPULATIONS [J].
COLES, SM ;
KLEIN, HG ;
HOLLAND, PV .
TRANSFUSION, 1981, 21 (04) :462-466
[6]   Spatial organization of gene expression: the active chromatin hub [J].
de Laat, W ;
Grosveld, F .
CHROMOSOME RESEARCH, 2003, 11 (05) :447-459
[7]   Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells [J].
Fibach, E ;
Bianchi, N ;
Borgatti, M ;
Prus, E ;
Gambari, R .
BLOOD, 2003, 102 (04) :1276-1281
[8]   MOLECULAR-BASIS OF BETA-THALASSEMIA IN THAILAND - ANALYSIS OF BETA-THALASSEMIA MUTATIONS USING THE POLYMERASE CHAIN-REACTION [J].
FUCHAROEN, S ;
FUCHAROEN, G ;
SRIROONGRUENG, W ;
LAOSOMBAT, V ;
JETSRISUPARB, A ;
PRASATKAEW, S ;
TANPHAICHITR, VS ;
SUVATTE, V ;
TUCHINDA, S ;
FUKUMAKI, Y .
HUMAN GENETICS, 1989, 84 (01) :41-46
[9]   GERM-LINE TRANSMISSION AND DEVELOPMENTAL REGULATION OF A 150-KB YEAST ARTIFICIAL CHROMOSOME CONTAINING THE HUMAN BETA-GLOBIN LOCUS IN TRANSGENIC MICE [J].
GAENSLER, KML ;
KITAMURA, M ;
KAN, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11381-11385
[10]   IMPORTANCE OF THE GENETIC PICTURE AND GLOBIN-SYNTHESIS IN DETERMINING THE CLINICAL AND HEMATOLOGICAL FEATURES OF THALASSEMIA INTERMEDIA [J].
GALLO, E ;
MASSARO, P ;
MINIERO, R ;
DAVID, D ;
TARELLA, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 41 (02) :211-221